The British Veterinary Association has expressed concern about an increasing trend towards temporary contracts for new graduates following the release of headline figures of a survey by the Institute for Employment Studies on behalf of the RCVS.
The survey showed that the percentage of graduates leaving their first job within the first three months has significantly increased for those who graduated in 2012 and who have already left their first position. Amongst vets who graduated in 2010 and had already left their first job 7.7% had done so within the first three months; for 2011 graduates this figure is 15.9%; and for 2012 graduates it is currently 42.6%, although this percentage is likely to decrease over the next year as more of the 2012 cohort leave their first roles. The two main reasons given for leaving first jobs are poor management and temporary contracts.
Besides this unexpected increase the survey showed little change in other areas for recent graduates, although there has been a slight increase in the amount of time taken for new graduates to find their first job. The survey also revealed that over the 5 year period 16% fewer graduates found jobs in under 3 months.
BVA President Peter Jones said: "Information in this survey and that conducted by the British Equine Veterinary Association recently is valuable evidence of how the changing environment affects those entering our profession and will feed into the on-going discussion at BVA on veterinary workforce issues.
"Perhaps most worrying is the statistic that the percentage of graduates leaving their first job within the first 3 months has significantly increased. The main reasons cited are poor management and temporary contracts. The trend towards temporary contracts is very worrying in terms of job security for those just starting out in our profession.
"Poor management has long concerned the BVA and is what initially led us to establish initiatives such as the Young Vet Network, the recent graduate guide and our contracts of employment campaign. We are currently working on building that support and we are in the process of widening the network of graduate support meetings to help with moral support and networking opportunities. We also supporting the RCVS's Professional Development Phase to support new graduates in their first few years of practice and have produced a number of resources to assist with this process."
While the results show little evidence of a major impact on job prospects from the increase in graduates since the opening of Nottingham Veterinary School, BVA members remain concerned about the impact of a new school opening next year such as the one planned at the University of Surrey.
Peter Jones continued: "It is reassuring to see that overall trends are not changing significantly, however, the ease with which our graduates are getting jobs is changing. We will therefore be considering in some depth the impact that two, three or more new veterinary schools could have in the future. Rumours of yet more new veterinary schools elsewhere are a serious worry for the profession.
BCF Technology has launched the Cuattro Small Animal DR, a digital radiography system which it describes as 'revolutionary for the small animal veterinary practice'.
BCF says the system transforms small animal practices' imaging function, producing diagnostic X-ray images in 5 seconds.
Craig Hoines from BCF said: "The Cuattro Small Animal DR is a smart investment for any practice looking to grow and expand. Investing in your imaging function is a perfect way to do this. The Small Animal DR will allow you to cut X-ray study time significantly, improve in-practice workflows and speed up patient care without increasing costs. The team at BCF can show you how."
According to the company. the Small Animal DR can be practical investment for any size of small animal practice.
For more information, visit www.bcftechnology.com or call +44(0)1506 460 023 to arrange a demonstration.
The Royal Mail has launched Dog Awareness Week (15th-19th July) to raise awareness of dog attacks on Royal Mail's postmen and women, and appeal to dog owners to keep animals under control when the postman calls.
The Royal Mail says dog attacks are a significant hazard faced by postmen and women on a daily basis. Attacks rise during the school holidays and in the summer months when parents and children are at home and dogs are sometimes allowed unsupervised in the garden, or out onto the street without restraints.
Since April 2011, there have been over 5,500 attacks on Royal Mail postmen and women, some leading to a permanent disabling injury. Attacks have resulted in the loss of 4,100 working days due to injuries.
Whilst the number of attacks has fallen by 24% nationally since 2011, over 2,400 postmen and women were still attacked by dogs in the year ending April 2013.
Currently, legal protection against attacks by dogs does not extend 'beyond the garden gate'. This is a particular problem for postmen and women, who each visit hundreds of private addresses every day on their delivery rounds. The Royal Mail says it welcomes the Government's commitment to amend the previous legislation to ensure its postmen and women will be protected when they enter private property, including gardens.
Shaun Davis, Director of Health, Safety and Wellbeing for Royal Mail Group said: "For the first time, we are holding a Dog Awareness Week working with the CWU, animal charities and organisations to raise awareness of the problems our postmen and women face daily when they are delivering the mail.
"We are delighted to be supported by a wide range of organisations and animal charities including Dogs Trust, DEFRA, Blue Cross, Wood Green, and the Association of Dog Wardens.
"We have held a number of previous one day campaigns and the awareness of the issue of dog attacks is growing. Last year the number of dog attacks on our people fell. However there were still over 2,400 incidents and we need to reduce this number further as even one dog attack on our people is one dog attack too many.
"Clearly most dogs are not inherently dangerous, however, even the most placid animal can be prone to attack if it feels its territory is being threatened. Our first priority as an employer is to ensure the welfare and safety of our people who provide a valuable service to our customers and we appeal to owners to keep their pets under control, especially if they know their pets have a territorial nature."
Freelance Surgical Ltd has announced a limited offer under which it will supply all of the instrumentation and capital equipment required for a veterinary practice to set up a new laparoscopy service, for £10,000 +VAT
The company says it has seen a substantial number of requests for laparoscopic instrumentation and capital devices in recent months. James Towler, Veterinary Director said: "Keyhole surgery is becoming increasingly popular within the veterinary field and the driving force is the client. They are now more informed of the benefits of what this type of surgery can offer. Our goal is to be able to provide veterinarians with an affordable package that will allow them to cater to client request s rather than referring the patient to their competitors."
Freelance Surgical says using laparoscopy has proven for many to generate a new revenue stream as well as offering improved patient outcomes. According to the company, a practice performing 6 bitch spays a week can generate over £50,000 in just 3 years*
For more information contact Freelance Surgical on 0845 050 4147or visit: www.freelance-veterinary.co.uk
The RCVS Registered Veterinary Nurse Disciplinary Committee has suspended a Northants-based registered veterinary nurse who admitted to acting dishonestly with her employer, a client and a pet database company by taking home a patient that was supposed to have been euthanised.
During the two-day hearing, the Committee heard how Sally-Ann Roberts, formerly of the Best Friends Veterinary Group in Thrapston, had deliberately gone against the wishes of the owners of a 14-year-old Maine Coon cat called Jason that he be euthanised, rather than treated further, and instead had taken the cat home with her for "intensive nursing". Jason had subsequently escaped from Ms Robert's residence, leading her to fabricate a story, first to the pet database company, and then to Jason's owners and her employer, that he had escaped from the practice, before being returned by a member of the public two days later and then euthanised as originally requested.
Ms Roberts acted with her veterinary surgeon colleague Przemyslaw Bogdanowicz, who chose not to euthanise Jason and who, for his part, received a three-month suspension from the RCVS Disciplinary Committee in December 2012. She repeated the false account on a number of occasions, both orally and in written statements, and also forged the signature of Jason's owner on official documentation in order to substantiate her story.
Only when Ms Roberts was interviewed for a second time by her then employer's area manager, did she finally admit to what had actually happened. Shortly afterwards, Ms Roberts was suspended from the practice and, following an internal disciplinary hearing a few days later, was dismissed by them for gross misconduct, along with Mr Bogdanowicz. There was no evidence available as to what ultimately happened to Jason.
Explaining her actions to the Committee, Ms Roberts said she was upset that Jason's owners wanted him to be euthanised and felt that he could recover if given some love and attention. She had asked Mr Bogdanowicz to discuss this possibility with Jason's owners, but he had refused, agreeing instead that she could continue Jason's treatment at her home. After Jason escaped, Ms Roberts said she was "devastated" and had "panicked", inventing the story of Jason's escape to cover her actions, which she now acknowledged were "wrong" and "stupid", and which she "bitterly regretted". Ms Roberts expressed sorrow and remorse for her behaviour, which she said would never occur again, and stated that being a veterinary nurse was everything to her.
In view of the admitted facts, the Committee judged that Ms Robert's dishonesty and breach of client trust, as well the distinct risk of injury to which she exposed Jason, amounted to serious professional misconduct. In deciding on an appropriate sanction, the Committee balanced a number of aggravating factors (in particular, the forged signature) against Ms Roberts' "strong mitigation", which included her admitting the entirety of the charges against her, her medical and personal problems at the time, the insight she had shown into the effects of her actions on Jason's owners and her previous unblemished career.
Professor Peter Lees, chairing and speak on behalf of the Committee, said: "The Committee has concluded that the Respondent has shown insight into the seriousness of her misconduct and that there is no significant risk of repeat behaviour. In light of the Respondent's admission, her insight, her remorse and the high regard in which she is held by her professional colleagues, it is the Committee's view that the sanction of two months' suspension is appropriate and proportionate."
The Committee's full decisions on facts and sanction are available at www.rcvs.org.uk/disciplinary.
Zoetis has relaunched a broad spectrum intramammary treatment for clinical mastitis, as Lincocin Forte S.
For vets seeking to prescribe an alternative first-choice tube, independent mastitis authority Dr Andrew Bradley suggests it could be a logical, efficacious option, offering the combination of two active ingredients (lincomycin and neomycin) not available in other intramammary tubes.1
Zoetis points to studies which show that In combination, these have been found to have much higher efficacy than the sum of the two parts against Staphylococci aureus.2&3
The company says Lincocin Forte is effective against Gram positive and Gram negative pathogens, in particular staphylococcus, streptococcus and coliform bacteria.
In trials, the treatment produced clinical cure rates 21% higher than an ampicillin-cloxacillin comparison in undifferentiated mastitis cases. As first choice treatment for S uberis clinical mastitis, bacteriological cure rates were similar to a penicillin-streptomycin comparison.4 Against S aureus, aesculin-positive streptococci, and E coli, combined clinical-bacteriological cure rates were 175%, 32% and 21% higher respectively with Lincocin Forte S than ampicillin-cloxacillin treatment.
Zoetis vet Jude Roberts said these findings underpin the treatment's relaunch and its suitability as a first choice therapy for new clinical mastitis cases.
Lincocin Forte S is a water-based formulation, which Jude says helps achieve good distribution in the udder and can be easier to infuse that oil-based tubes, particularly into hardened quarters associated with E coli infections.
Dr Bradley adds that water-based formulation is likely to be less irritant to udder tissues than oil-based tubes, and may improve distribution. He also suggests that "not being a fluoroquinolone or 3rd/4th generation cephalosporin may also help vets fulfil their 'appropriate and justified' prescribing responsibilities."
The recommended treatment is one 10ml syringe per infected quarter at each of three consecutive milkings. Milk from treated cows can be sold for human consumption 84-hours after the last treatment.References:
Purina has launched a FortiFlora veterinary support pack designed to help veterinary professionals advice owners about their pet's intestinal health and balance.
The support package includes a "Training Toolbox" with Lunch and Learn sessions to help guide veterinary professionals through the introduction of Fortiflora to an owner. It explains the indications, ingredients, benefits and summarises the added value in prescribing to animals with specific health issues. In addition, there are leaflets for owners explaining what probiotics are and how they can help support a pet's intestinal health on a daily basis, as well as some testimonials from owners explaining how Fortiflora has helped their pets. Promotional bunting and posters are designed to raise awareness in the waiting room, and for a short time there is a promotional pillow pack available to allow clients easy access to a short course of FortiFlora.
In a recent survey of pet owners conducted by Purina, 66% of respondents said their dog had suffered with digestive problems and 80% said they would be willing to make a change to their dog's diet to improve their digestion.1
Purina says that providing a supplement such as FortiFlora is also recommended as a nutritional supplement to help with diarrhoea associated with stress, antibiotic therapy, diet change and acute enteritis. The company claims it can also help with situations associated with stress such as moving house, vet visits and shows.
Chris Nickson, Senior Brand Manager at Purina said: "Intestinal upset is a very common problem for dogs as our research highlighted. The aim of this support pack is to help vet practices initiate the conversation with owners to ensure they are aware of the benefits that a nutritional supplement like FortiFlora can offer."
FortiFlora is suitable for use in cats and dogs of all ages. Animals should be fed one sachet of FortiFlora per day sprinkled over the pet's regular food.
For more information or to request a FortiFlora support pack, call Purina on 0800 212 161.
Reference
A new study, published in the Equine Veterinary Journal (EVJ)1 has concluded that whilst horse owners are increasingly looking to vets for worm control advice and use faecal worm egg counts more frequently, they remain largely unaware of the threat of resistance to dewormers and the importance of appropriate 'targeted' dosing.
The authors of the study say that although the findings are encouraging, they indicate that further effort is needed to help owners fully understand the issue of dewormer resistance, in order to help preserve the efficacy of dewormers currently available and protect the health and welfare of their horses.
According to the British Equine Veterinary Association (BEVA), resistance of equine gastrointestinal worms to the currently available dewormers is a serious problem. The association says small redworm are the greatest concern, given their very high prevalence, potential to cause life-threatening disease and high levels of resistance. Of the three classes of anthelmintic available for their control, there is now widespread resistance to benzimidazoles (e.g. fenbendazole) and tetrahydropyrimidines (e.g. pyrantel) and reduced effectiveness of macrocyclic lactones (ivermectin and moxidectin). With no new classes of dewormer on the horizon, it's essential that efficacy of existing effective products is preserved.
The study was conducted by a UK team, led by Claire Stratford, Horse Trust Clinical Scholar in Equine Medicine at the Royal (Dick) School of Veterinary Studies, and at Moredun Research Institute. The collaborators were also supported by funding from the Elise Pilkington Trust and Horserace Betting Levy Board.
The study examined equine helminth control practices in Scotland, and was based on responses from 193 questionnaires detailing the parasite control programmes of 993 horses and ponies. The results demonstrated a lack of awareness of the significance of dewormer resistance, with 86% of respondents stating that they were unaware of the presence of resistance on their yard. The majority were relatively unconcerned about dewormer resistance, assigning a score of only 6/10 (with 10 representing highest level of concern) when asked to grade how important they perceived it to be.
On a more positive note, many respondents stated that they involved their vet in planning control strategies. Faecal worm egg count (FWEC) analysis had been performed on 62% of yards and annual treatment frequency had been reduced accordingly. The macrocyclic lactones or related combination products were the most commonly administered products; however, owners did have misconceptions regarding the specific worms they should be targeting.
Although treatments licensed for use against encysted small redworm larvae were administered by 80% of respondents, only 57% perceived that they treated for this parasite stage. Similarly, only 78% of respondents believed they were treating for tapeworm when, in fact, 90% reported using a product licensed for tapeworm treatment.
While responses indicated increased implementation of strategic (44% respondents) or targeted control (40% respondents), variations in the apparent influence of the targeted approach on treatment practices suggested some confusion over this term. Claire Stratford said: "Targeted dosing involves using regular FWEC analysis to identify an individual's egg shedding level. This is currently considered best practice, when used in conjunction with annual dosing against encysted small redworm and tapeworm. The survey indicates a need for continued knowledge transfer, together with a consistent definition of 'targeted' treatment."
Professor Celia Marr, Editor of Equine Veterinary Journal said: "It's very encouraging to see that vet advice is being increasingly sought and it seems logical that the use of FWECs is rising accordingly. But, it is equally important that the information gained from the FWECs is used wisely. Resistance to dewormers is a major health concern that is with us right now and horse owners need to be made more aware of it."
Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.
Flexi4 contains a blend of four plant extracts, Curcumin, Yucca schidigera, Salix alba and Boswellia serrata, which the company says have been shown to have anti-inflammatory, anti-pyretic and analgesic properties as follows:
Mary King, Olympic three day eventing team silver medallist, said: "When performing at the highest level it's important that my horses' joints remain flexible and free of pain. Using Flexi4 has made them more resilient to aches and pains during intense training and I am confident when competing that my horses are feeling the benefit of this natural product, helping them to perform at their very best."
Flexi4 is an apple-flavoured gel that is fed as a once daily supplement. It doesn't contain any substances listed as prohibited by the FEI.* For more information, contact your Zoetis Account Manager, call 0845 300 8034 or email customersupportuk@zoetis.com.
References
*FEI prohibited substance list, 2013
BCF has released a new bovine foetal sexing quick guide as a free download from the farm animal learning section of the company's website - www.bcftechnology.com.
To help vets learn the skill of foetal sex determination with ultrasound, the guide includes:
BCF says that using ultrasound for foetal sex determination can be useful to herd management programmes: you can estimate the number of replacement heifers, further justify the culling of a cow with chronic disease (mastitis, lameness etc.) and determine pricing for a sale and/or purchase.
The guides have been created by BCF in-house vet Kimberley Palgrave who said: "The bovine foetal sexing guide was created with the aim of giving vets a few tips to help them develop confidence in foetal sex determination using ultrasound. Hopefully this guide can help people feel more assured in their technique and enable them to obtain additional information that the farmer can use in their herd management programme."
The RCVS Disciplinary Committee has directed that the name of a veterinary surgeon who formerly practised in Norwich should be removed from the Register, having found him unfit to practise veterinary surgery following his Crown Court conviction for fraud.
During the one-day hearing, the Disciplinary Committee heard how Francisco da Cruz had abused his position whilst practising as a veterinary surgeon at Hellesdon Vets, his then workplace in Norwich, by defrauding a insurance companies of around £10,000 with fictitious claims for veterinary treatment on non-existent pets.
Following an investigation by the City of London Police's Insurance Fraud Enforcement Department (IFED), Mr da Cruz was convicted on five counts of fraud by false representation on 21 February 2013 at the Old Bailey in London, and later sentenced to eight months' imprisonment (suspended for two years) and 200 hours of unpaid community work; he was also ordered to pay just over £10,000 in compensation and costs.
Although Mr da Cruz had left the UK for Brazil shortly after his sentencing and was therefore not present at the hearing, the Committee was satisfied that he was deliberately evading the disciplinary proceedings, rather than being genuinely unable to participate in them, and so the hearing proceeded in his absence.
First accepting the copy certificate of conviction against Mr da Cruz as true, the Committee then had no hesitation in concluding that these convictions rendered him unfit to practise as a member of the veterinary profession. It found that the five counts of fraud were deliberate crimes of dishonesty, committed over a significant period of time and for significant financial gain. He had abused his position as a veterinary surgeon and abused the trust which the insurers placed in him as a professional.
Chairing and speaking on behalf of the Committee, Professor Peter Lees, said: "The Committee has no real confidence that there is no significant risk of repeat behaviour from the Respondent. His conduct subsequent to the criminal proceedings gives it no confidence that he has reformed himself to the extent that he will in the foreseeable future be fit to return to practice. So far from satisfactorily completing his criminal sentence, it appears that the Respondent has deliberately gone abroad to avoid doing so."
Bearing in mind that the purpose of any sanction it imposed was not to punish Mr da Cruz, but to maintain public confidence in the profession and uphold proper standards of conduct within it, the Committee concluded that the convictions were too serious to allow any sanction other than removal from the Register.
The full details of the Committee's decisions are available on the RCVS website (www.rcvs.org.uk/disciplinary).
Following the outcry from the profession over the disciplinary hearing into Mr M Chikosi, the RCVS' new Operational Board has clarified the the College's position on the use of blankets to move animals.
The hearing found Munhuwepasi Chikosi guilty of unreasonably delaying attending a dog that had been run over at a farm, and of unnecessarily causing her to remain in pain and suffering for at least an hour.
As a result, the Disciplinary Committee directed that Mr Chikosi's name be removed from the Register for serious professional misconduct. The College says that since the appeal window has closed without an appeal being made, Mr Chikosi has now been struck off.
However, the Committee also said: "... his [Mr Chikosi's] advice that Mitzi should be moved on a blanket was wrong, as she may have had an injured back."
This was widely criticised as being out of touch with the practicalities of real life and unsupported by any evidence.
Speaking on behalf of the Board, President Neil Smith said: "We fully support the decision taken by the independent Disciplinary Committee with regard to the Chikosi hearing, with one comment requiring clarification: the issue of whether a blanket can be used to move an injured dog. We consider that it is acceptable, in most cases, to transport an injured dog with the aid of a blanket.
"The profession should be reassured that our Standards Committee [the new name for Advisory Committee] will consider the general issues raised by the Chikosi hearing at its next meeting. This will not be a review of the decision, but form part of the routine consideration of DC hearings made by the Committee to see if they raise issues that require additional guidance and advice."
Zoetis has launched a 4ml vial of the antibiotic, Convenia.
Zoetis says Convenia gives veterinary surgeons control by providing an assured injectable treatment course, relieving clients of the burden of daily dosing. This avoids missed or mistimed doses, lost tablets, or courses stopped too soon, thereby eliminating a major reason for treatment failure, non-compliance. Poor compliance is also a significant factor in the development of antimicrobial resistance.
Convenia is licensed for skin, soft tissue and urinary tract infections in dogs and cats, as well as severe gingivitis/periodontitis in dogs (as an adjunct to mechanical or surgical periodontal therapy). A 4ml vial can treat up to 40kg of bodyweight, making it appropriate for treating cats and smaller dogs.
Zoetis says that the launch of the new vial demonstrates its commitment to the 'Respect Antibiotics' campaign launched last year. The Respect Antibiotics campaign encourages careful and informed selection of appropriate antibiotic therapies for the treatment of dogs and cats.
Product Manager, Andrew Page, said; "We are committed to encouraging responsible antibiotic usage, and reducing the incidence of antibiotic resistance. Non-compliance plays a key role in the development of antibiotic resistance and we hope that by making Convenia more accessible through the introduction of a 4ml vial we can help alleviate compliance issues."
For further details about Convenia please contact your Zoetis Account Manager.
The RCVS has published a video in which the new President Neil Smith outlines his objectives for the year ahead.
In the video, Neil says the presidential task he most looks forward to is admitting new veterinary surgeons and nurses to the Register. There have been 740 registrations made as part of graduation ceremonies across the UK's seven veterinary schools this summer.
Neil said: "It's a great privilege to welcome these new graduates to the College. Graduation represents a culmination of such a long period of hard work - supported by family, friends and vet school staff. It's also the start of what I hope will be satisfying lifelong careers in a profession that is proud to keep animal health and welfare at its heart.
"I hope that this latest generation of veterinary surgeons will benefit from the broad range of career opportunities available, just as the animal-owning public will benefit from their skills and knowledge."
On graduation, all new veterinary surgeons received a memory stick from the College, which included a Guide for New Members, the Code of Professional Conduct, CPD Record Card, information about the Professional Development Phase, which is mandatory for all new graduates working in clinical practice, and other College publications. If any new graduate did not receive their memory stick, they should contact membership@rcvs.org.uk.
BCF Technology has announced the launch of View Cloud Web, a picture archiving and communication (PACS) system.
View Cloud Web is an online storage system that allows you to store, view, report and share diagnostic images.
BCF says you can access your images from any device connected to the web, without the need to download any special software. The company also says the software is intuitive to use, and should require no special training.
Sean Stevenson from BCF said: "The popularity of View Cloud Web already, is testament to how easy the software is to use and how simple it is to get the customer up and running with the product. Customers love the fact that it is accessible from any web connected device, meaning they can view their images from anywhere in the practice, at other branches or even at home if they want to."
To find out more about View Cloud Web visit www.bcftechnology.co.uk or call +44(0)1506 460 023 to arrange a demonstration.
Virbac has been granted a Limited Marketing Authorisation in the UK for its Gudair vaccine, indicated for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (MAP).
MAP is the causal organism for Johne's Disease, a chronic infection of the intestinal system for which there is no cure.
According to Virbac, Johne's Disease enters most flocks following the introduction of infected stock, often breeding rams, bought at markets without checks on disease provenance. It is then spread by the faeces of often apparently healthy animals but which can contain huge numbers of MAP. The main clinical sign is a thin ewe resulting in poor productivity followed by inevitable death. It can be passed between sheep and cattle.
Ovine Johne's Disease (OJD) in sheep is widespread in Australia where annual death rates of up to 17% have been seen in infected flocks. Virbac says that trials conducted there have demonstrated that vaccination with Gudair can reduce the number of deaths due to OJD by 90% and reduce the numbers of OJD-causing organisms excreted in sheep faeces by 90%.
Ken Sibley MRCVS, Technical Advisor at Virbac says that the number of infected flocks in the UK is unknown and the disease often remains undiagnosed: "Johne's Disease can be a significant cause of loss in infected sheep flocks because of reduced productivity and high culling rates. Vaccination provides the only possible assurance when sourcing sheep from potentially infected flocks and will help to reduce losses from the disease should a farmer inadvertently introduce sheep into an infected flock.
"Lambs identified as replacements should generally be vaccinated between 4 and 16 weeks of age, subcutaneously behind the ear. Sheep over 16 weeks of age can also be vaccinated as this will reduce shedding of organisms in infected animals while bought-in replacements can be vaccinated on arrival at the farm. Sheep require only one vaccination for their lifetime.
"Following its success in Australia, we are delighted to be able to offer Gudair to veterinary surgeons in the UK."
For further information, contact your Virbac territory manager or call: 01359 243243
Veterinary charity PetSavers has launched its annual photography competition, and is inviting vet practices to get involved.
PetSavers is asking veterinary practices to help promote the annual PetSavers photography competition by encouraging their clients to take part. This year's theme is 'Mischievous Pets', and the competition is free to enter, with a closing date for entries on the 31 January 2014.
PetSavers' studies have already contributed a better understanding of many common diseases such as diabetes, cancer, arthritis and heart disease to the profession. However, there is obviously a lot more work to be done. By promoting the photo competition, you will help PetSavers to tell its story and encourage more pet owners to support the kind of veterinary science that helps vets improve the health of the nation's pets.
You can help promote the competition by placing a poster on you practice notice board or downloading a digital copy and placing it on your social networking sites or practice newsletters.
To request a poster of for more information about how you can get involved with PetSavers visit www.petsavers.org.uk or email Emma - e.sansom@bsava.com. Of course - all vet and VN photographers can enter too.
Ceva Animal Health has rebranded its nutraceutical supplements for cats and dogs under its Logic brand.
The new Logic range, which previously included the company's dental products, now includes Logic Diar-Stop (previously known as Diarsanyl Plus) for digestive health, Logic Flexivet, a joint supplement and Logic Senilife, a nutraceutical which Ceva says has been shown to manage the signs of brain ageing.
The range is available in consumer-friendly packaging and a merchandising unit is available to showcase the products in practice.
Claire Russell, consumer product manager at Ceva Animal Health said: "The new Logic range provides veterinary practices with an extensive portfolio of respected veterinary strength supplements and dental products, with more exciting and innovative products to come in the pipeline."
For further information on the Logic range, visit www.logicforpets.co.uk, contact your local Ceva Animal Health territory manager or call Ceva's customer support team on 01494 781510.
Improve International has launched a new course for veterinary receptionists to achieve the nationally accredited Edexcel QCF Level 2 Certificate in Customer Service, but with the assessment tailored specifically to demonstrate excellence in veterinary client care.
Veterinary receptionists may be able to benefit from government funding to enable them to study for the qualification, which Improve says can be delivered either at its HQ in Swindon or in practice.
Government funding is available for students of the Certificate in Customer Service without an existing Level 2 qualification in another subject. Requests also depend on the age of the learner and will be assessed on an individual basis by Improve's local Edexcel accredited centre in Swindon.
The 30 hour course features three core units, assessed by a one hour online test:
David Babington MRCVS, founder of Improve International said: "A successful veterinary practice is no longer just about a 'good' vet or nurse. It's about a practice team pulling together and playing their role to the top of their ability. The key role played by receptionists in terms of creating that vital first impression and helping to maintain client loyalty cannot be understated and we wanted to offer them a form of training that would help them develop their skills while achieving a nationally recognised qualification. We look forward to welcoming our first students later this year."
For further information or to register, email enquiries@improve-international.com; visit www.improvecpd.com or call 01793 759159.
Elanco Companion Animal Health has launched a dermatology e-newsletter called Under The Skin, designed to help veterinary professionals stay informed and up to date on a wide range of skin conditions.
Featuring a guest editor for each edition, experts will review interesting case studies and research papers and discuss diagnosis and treatment options.
The launch issue focuses on otitis and is edited by Dr Peri Lau-Gillard DerMedVet CertVD DipECVD MRCVS, European Specialist in Veterinary Dermatology.
Topics include a review of a clinical case - Pseudomonas otitis in a Cocker Spaniel called Rosie, a video otoscopy before and during Rosie's ear flush, information on antimicrobial resistance (AMR), a discussion on whether to carry out in-house ear cytology, product information on Surolan and a review of the causes of otitis.
The newsletter also features hints and tips on how to prevent contamination of ear medication/ear cleaners, the importance of marking products with expiry dates, information on applying topical ear cleaners/ear medication and owner education on how to apply the medication.
To receive priority notification of future editions of Elanco's 'Under The Skin' e-newsletter, register at www.thewebinarvet.com/elanco
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 353131.
Virbac has launched Marfloquin, a marbofloxacin-based antibiotic indicated for the treatment of multiple infectious diseases in cats and dogs.
Marfloquin is presented as a palatable, divisible tablet for once daily administration and is available in three tablet strengths:
Virbac Companion Animal Marketing Manager Simon Boulton MRCVS said: "Marbofloxacin is valued by practices for its efficacy in treating a wide range of skin, soft tissue, urinary tract and respiratory tract infections. The launch of Marfloquin gives them a cost-effective alternative and strengthens our existing antibiotic range, which includes Rilexine (cefalexin) and Enrox (enrofloxacin)."
For more information, contact your territory manager or call Virbac on 01359 243243
IDEXX Laboratories has unveiled the Angio Detect Test, a world-first diagnostic test which allows veterinary surgeons to detect the lungworm Angiostrongylus vasorum in clinic, with almost immediate results.
Until now, vets have had to rely on the Baermann method to detect A. vasorum, which can present with varied and confusing clinical symptoms. However, the Baermann test has had limited use because it requires faecal samples from the same dog to be collected on three successive days, and the results can be compromised by the intermittent shedding of larvae. IDEXX says this leads many experts to believe that A. vasorum is widely under-diagnosed.
The Angio Detect Test works by detecting an A. vasorum specific antigen in the animal's blood. The test can be used in-clinic using a serum or plasma sample and returns results within 15 minutes. Depending on results, you can offer a licensed treatment or talk about a preventative treatment regime and refer the client to a source of further information, such as lungworm.co.uk.
IDEXX suggests that because the test is inexpensive, it can be used for the diagnosis of A. vasorum suspect dogs and in those with non-specific signs. Indeed, in market research1, 94% of veterinary surgeons said they would use the test in dogs presenting with A. vasorum signs.
In endemic areas, it can be considered as an additional pre-surgical measure to avoid complications associated with coagulopathy.
This test comes at a time when concern about A. vasorum has been growing. A survey of 150 veterinary practices across the UK in January 2013 recorded a total of 952 suspected cases (157 laboratory confirmed), with 81 deaths thought to have been caused by the parasite2. The Angio Detect Test should help to improve the picture, as confirmed cases are logged onto incidence maps so vets can check prevalence in their area.
Ian Wright from the European Scientific Counsel Companion Animal Parasites (ESCCAP) said: "In recent years, there has been spread of the A. vasorum parasite across the UK with cases now being reported as far north as Scotland. It was initially thought this may be due to increased reporting rather than genuine spread, but this pattern in the UK has been mirrored in many other countries and would appear to represent a true emergence of disease. Although the cause of this spread is not known for certain, increasing slug and snail numbers combined with increased pet movement and urbanisation of foxes are all likely to have played a significant part. These factors make A. vasorum a year round rather than seasonal threat.
"Any new diagnostic test that can quickly confirm a case of lungworm is a fantastic development and will help save dogs' lives and give us even greater insight into the extent of the spread of the parasite."
Graham Bilbrough, veterinary surgeon and European medical affairs manager for IDEXX Laboratories, said: "Up until now, testing methods have been time consuming to the client and costly, so the launch of the Angio Detect Test, together with recognition of clinical signs and early treatment will really help to prevent A. vasorum related fatalities in dogs. We also know that some dogs have subclinical angiostrongylosis, and this new test will help uncover this hidden problem before the surgical blade makes a cut. Difficulties in diagnosis have also meant that the full prevalence of A. vasorum in the UK has been relatively unknown. This test will allow veterinary surgeons to quickly identify the parasite and treat it if found. They shouldn't forget that other dogs in the household and the area are also at particular risk from the parasite."
The Angio Detect Test is available now in the UK, and will be launched in other European countries later this year. For more information on the test, visit www.idexx.co.uk/angio or speak to your IDEXX sales representative. For further information and free CPD on A. vasorum and other parasites, visit www.jungleforvets.co.uk or speak to your Bayer territory manager.
Dechra Veterinary Products has launched Myorelax, a guaifenesin 100 mg/ml solution for infusion for horses which, the company says, relaxes skeletal muscles within minutes.
Dechra's Equine Brand Manager Emma Jennings said: "Myorelax is indicated for the induction of muscle relaxation and immobilisation, as an adjunct to balanced anaesthesia.
"We're delighted to launch this product, which can be combined with a number of sedatives and anaesthetics including detomidine, ketamine and propofol plus local and volatile anaesthetics.
"Myorelax is a centrally acting muscle relaxant which is effective within a few minutes and does not affect the animal's respiratory muscles at therapeutic doses. It can be used in combination with a sedative and local anaesthetics for short procedures and together with appropriate general anaesthetics for induction and maintenance of muscle relaxation during anaesthesia."
Dechra says that horses are able to stand within 45 minutes after single administration, and the product can be used in a 'triple drip' protocol for total intravenous anaesthesia.
Myorelax is available in 500 ml bottles from veterinary wholesalers.
For further information, visit www.dechra.co.uk
Royal Canin is launching a new packaging format for its range of feline wet diets.
The company says the launch comes in response to research showing that more than three-quarters of pet owners (76%1) feed their cats wet food and almost half of wet cat products sold are in a canned format (48%2).
The current alutray packaging will be replaced by 195g cans, which Royal Canin says are easier to use and store, and which clients believe to be better value for money than other packaging formats.
The new cans will contain the same recipes as before, with the same balance of nutrients in each wet diet. They will consist of a loaf or mousse, providing a complementary texture to the chunks in gravy found in the equivalent pouched diets.
Royal Canin is also highlighting the benefits for veterinary practices: The cans are designed to provide greater clarity of display and on-shelf presence. They are also easier to stack for storage, and they meet an established demand.
Ian Williams, one of Royal Canin's small animal vets, said: "We believe the new packaging is an improvement on our established and popular range of wet Veterinary Diets for cats. The range is extensive which allows owners to follow a vet's nutritional recommendations without changing their pets' feeding habits, an excellent way to increase compliance."
The new canned format will be phased in as stocks are replenished, with the following cans being added to the Royal Canin range of wet feline foods: a new Renal and Urinary S/O can, joining the existing Recovery can within the range of Veterinary Diets; and a new Paediatric Weaning can within the Veterinary Care Nutrition range.
For more information about Royal Canin and the diets, visit www.royalcanin.co.uk.
Diagnostic imaging company BCF Technology is inviting veterinary surgeons to apply for a job as Clinical Manager by submitting a 2 minute video outlining why they would like to work for the company.
BCF Managing Director Gavin Mitchell said: "We are looking for somone with a real passion for imaging and desire to help improve the quality of veterinary imaging. Part of the role will involve presenting clinical learning videos, so we thought it would be a fun way to approach the recruitment process with candidates sending in their own home-made videos. So get creative and you could come and work with us and help vets learn more about 256 shades of grey."
BCF in-house vet Kimberly Palgrave said: "This role is a great opportunity for a vet wanting to help others to improve their confidence and skills in using ultrasound and X-ray, it is a hugely rewarding role. It is also a very diverse role as BCF is a worldwide company. BCF approaches everything in a fun, innovative way, including the recruitment process."
BCF Human Resources Manager, Kim McLean, said: "As we are offering a job role that is quite unique, we thought we would approach advertising the job in a bit of a non-conventional way as well. We hope that candidates will take on the challenge and that we will receive some interesting video applications for the role.
To help potential vets learn more about the role and what it is like to work for the company, BCF has created a video which gives an overview of the business, has some comments from its staff and even has a rap about the company at the end performed by Tom from the Purchasing Department.
For more information about the job, visit www.bcftechnology.com/about-us/bcf-careers